Skip to content

We were incredibly honoured that the American Diabetes Association(ADA) featured PILA PHARMA AB in the Thought Leadership Film Series, a part of ADA’s 81st Scientific Sessions program in June 2021, starting today.

In the invitation letter, it was written: We are interested in profiling Pila’s pioneering research and development in the science surrounding TPRV1 inhibition, and how regulation of this mechanism has tremendous potential to be exploited for the treatment of diabetes.
Thank you so much to our scientific advisors Mark Evans and Jens Juul Holst for helping our previous CEO explain!

Watch the video in English here

(24 june 2021)


BIO International Convention

BIO International Convention
San Diego, US: Monday to Thursday, 3-6 June 2024

Please, find the link here

(22 May-2024)


Newly appointed CEO, Gustav H. Gram, hosts a Q&A with on PILA PHARMA’s changes with Founder Dorte X. Gram transitioning to Chairman of the Board and what changes and direction that investors can expect. The Q&A is conducted in English together with Anders Egsvang from

Please, find the link to the video (in English) here

(22 April-2024)
Back To Top